HNF1A Regulates Oxaliplatin Resistance in Pancreatic Cancer by Targeting 53BP1

Scientists explored the role of hepatocyte nuclear factor 1 homeobox A (HNF1A) in oxaliplatin resistance in PDAC and revealed that HNF1A expression was negatively associated with oxaliplatin chemoresistance in PDAC tissues and cell lines.